Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
AUTOR(ES)
Rosen, Oliver
FONTE
BioMed Central
RESUMO
Autoimmune diseases that are resistant to conventional treatment cause severe morbidity and even mortality. In the present study we demonstrate that complete remissions can be achieved in refractory polychondritis and systemic lupus erythematosus (SLE), even at advanced stage, with the use of autologous stem-cell transplantation (SCT). Remissions persisted after reconstitution of the immune system. In the treatment of advanced systemic sclerosis (SSc), stable disease may be achieved with autologous SCT.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17815Documentos Relacionados
- Immune ablation and stem-cell therapy in autoimmune disease: Experimental basis for autologous stem-cell transplantation
- Immune ablation and stem-cell therapy in autoimmune disease: Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation
- Immune ablation and stem-cell therapy in autoimmune disease: Introduction
- Immune ablation and stem-cell therapy in autoimmune disease: Clinical experience
- Clonal analysis of hematopoietic stem-cell differentiation in vivo.
